Notes for P&L

All amounts in SEKm unless otherwise stated

Note 6 Segment reporting


The division into business areas reflects AddLife’s internal organisation and reporting system. Operating segments are reported in a manner consistent with AddLife's internal reporting, which is submitted to the CEO, who has been identified as the highest executive within AddLife. AddLife reports business areas as an operating segment. AddLife reports its business areas as operating segments. The two business areas are Labtech and Medtech. This market grouping reflects a natural division of the Life Science market. AddLife uses EBITA (see definitions) as a performance measure when monitoring the business areas. Intra-Group sales are based on the same prices that an independent party would pay for the product.

Labtech

The companies in the Labtech business area operate within diagnostics and biomedical research, as well as laboratory analysis. The companies deliver directly to customers various products and solutions that include analytical instruments, equipment, microscopes, consumables and reagents, as well as software support and technical service, primarily to laboratories in medicine, research, academia and the food and pharmaceutical industries. The companies within the Labtech business area are mainly active in microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics and in the food industry. Customers are also offered training programmes in various areas to ensure that customers have the appropriate skills and to maximise user benefit for the products the Company provides.

Medtech

The companies in the Medtech business area provide medical device products within the medtech market, with a focus on surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare.

 

Data by operating segment

Download Excel

      2021 2020
Net sales     Externally Externally
Medtech     3,625.0 1,659.3
Labtech     4,373.0 3,618.5
Group items     -5.4 -4.5
Total     7,992.6 5,273.3
         
  2021 2020
EBITA EBITA EBITA
margin, %
EBITA EBITA
margin, %
Medtech 310.1 8.6 196.0 11.8
Labtech 976.9 22.3 622.0 17.2
Group items -13.7   -15.9  
Total 1,273.3   802.1  

Download Excel

  2021 2020
Operating profit/loss, assets and liabilities Operating profit Assets¹ Liabilities¹ Operating profit Assets¹ Liabilities¹
Medtech 85.4 8,127.2 941.2 120.9 2,135.0 407.2
Labtech 926.8 2,089.6 837.9 569.8 1,778.1 881.4
Group items -15.9 378.9 4,525.7 -18.2 236.5 970.7
Total 996.3 10,595.7 6,304.8 672.5 4,149.6 2,259.3
Finance income and costs -69.1     -13.5    
Profit before taxes 927.2     659.0    
¹ Does not include balances in Group accounts or financial transactions with Group companies.

Download Excel

  2021 2020
Investments in non-current assets Intangible¹ Property, plant and equipment¹ Total Intangible¹ Property, plant and equipment¹ Total
Medtech 1,825.6 233.9 2,059.5 189.2 56.0 245.2
Labtech 132.6 96.1 228.7 87.6 122.3 209.9
Group items 0.3 0.1 0.4 6.4 6.4
Total 1,958.5 330.1 2,288.6 276.8 184.7 461.5
¹ The amounts do not include the effects of corporate acquisitions.
             
  2021 2020
Depreciation/amortisation of non-current assets Intangible Property, plant and equipment¹ Total Intangible Property, plant and equipment¹ Total
Medtech -224.7 -101.9 -326.6 -75.2 -42.0 -117.2
Labtech -50.2 -96.7 -146.9 -52.1 -100.0 -152.1
Group items -2.1 -2.8 -4.9 -2.4 -2.5 -4.9
Total -277.0 -201.4 -478.4 -129.7 -144.5 -274.2
¹ Depreciation/amortisation of property, plant and equipment include depreciation/amortisation of right- of-use assets.

Download Excel

Significant profit or loss items, other than depreciation or amortisation, not matched by payments
  2021 2020
  Capital gains Change in pension liability Other items Total Capital gains Change in pension liability Other items Total
Medtech -1.9 -0.7 0.4 -2.2 -0.1 0.0 -5.7 -5.8
Labtech -1.4 -0.8 -6.0 -8.2 -3.6 -0.7 -1.3 -5.6
Group items -22.0 -22.0 14.4 14.4
Total -3.3 -1.5 -27.6 -32.4 -3.7 -0.7 7.4 3.0

Download Excel

  2021 2020
Data by country Net sales external Assets¹ Of which non-current assets Net sales external Assets¹ Of which non-current assets
Sweden 1,140.7 1,465.1 1,080.9 1,076.6 1,438.6 1,074.1
Denmark 1,158.1 682.4 397.7 820.4 472.5 273.7
Finland 648.4 260.0 131.0 704.4 264.6 131.1
Norway 1,008.5 484.2 280.0 830.1 471.5 276.2
Ireland 581.9 3,272.6 2,959.3
Germany 480.2 2,118.5 2,020.3 52.3 2.0 0.8
Other countries 2,974.8 2,224.6 948.8 1,789.5 1,465.6 680.1
Group items and unallocated assets 88.3 27.3 34.8 21.2
Total 7,992.6 10,595.7 7,845.3 5,273.3 4,149.6 2,457.2
¹ Does not include balances in Group accounts and financial assets. External net sales are based on the customers' location, and the carrying amounts of assets are based on where the assets are located.
             
  2021 2020
Investments in non-current assets Intangible Property, plant and equipment Total Intangible Property, plant and equipment Total
Sweden 46.4 20.6 67.0 37.7 33.8 71.5
Denmark 81.7 10.8 92.5 44.1 22.6 66.7
Finland 2.9 22.0 24.9 3.4 22.6 26.0
Norway 6.6 15.9 22.5 5.1 11.0 16.1
Irland 875.8 109.7 985.5
Tyskland 822.6 13.3 835.9 0.6 0.6
Other countries 122.5 137.8 260.3 186.5 94.1 280.6
Total 1,958.5 330.1 2,288.6 276.8 184.7 461.5
The Group has no single customer whose revenues account for 10 percent of total revenue, for which reason there is no related reporting.
To the top